by Ashley | Mar 18, 2022 | Blog, COVID-19, Stem Cell
Yes, you read that title right. Stem cell therapy for COVID-19 is helping elephants! As you may know, Personalized Stem Cells developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We later went on to license that trial to an outside...
by Ashley | Oct 1, 2021 | Blog, Clinical Trial, COVID-19, Stem Cell Therapy
For those who follow our blog, you are probably aware that Personalized Stem Cells (PSC) developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We then went on to out-license this clinical trial, along with our allogeneic stem cell...
by Ashley | Jun 1, 2021 | Clinical Trial, COVID-19, Press Release, Stem Cell
Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces the Brazilian Health Regulatory Agency (Anvisa) authorized a Phase 2 COVID-19 stem cell clinical trial. This approval comes shortly after the completion of a Phase 1b trial conducted...
by Ashley | May 14, 2021 | Blog, COVID-19, Stem Cell
In our most recent blog, we shared an update regarding the COVID-19 stem cell clinical trial that Personalized Stem Cells developed and secured FDA approval for. The trial, which we licensed to Sorrento Therapeutics, is studying the effects of allogeneic (donor...
by Ashley | May 4, 2021 | Clinical Trial, COVID-19, Press Release, Stem Cell
Just three months after the initial treatments, Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, announces enrollment is complete for COVID-19 FDA approved stem cell clinical trial licensed to Sorrento Therapeutics (Nasdaq: SRNE,...